GlassScriptPhysician profile
Mimi A Tran
NPI 1952331415
$5,003.36
in general payments reported to CMS, 2019-2025
18 companies · $933 in 2025
The $933 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $889 · 2022: $1,028 · 2023: $1,130 · 2024: $1,025 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,007.08 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,710.25 | 2021-2025 | |
| Incyte Corporation | $724.77 | 2022-2025 | Opzelura |
| Genzyme Corporation | $579.06 | 2021-2025 | |
| Janssen Biotech, INC. | $413.02 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Amgen INC. | $373.29 | 2023-2025 | Otezla, Otezla |
| Abbvie INC. | $333.30 | 2021-2025 | |
| Leo Pharma INC. | $279.65 | 2021-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $108.11 | 2021-2022 | |
| Genentech USA, INC. | $72.73 | 2022 | |
| Lilly USA, LLC | $67.00 | 2022-2023 | Olumiant, Taltz |
| Ucb, INC. | $61.09 | 2021-2024 | Bimzelx |
| Janssen Scientific Affairs, LLC | $60.00 | 2022 | |
| Galderma Laboratories, L.P. | $57.25 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $54.13 | 2023 | Winlevi |
| Sanofi-Aventis U.S. LLC | $46.01 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.40 | 2023 | Spevigo |
| E.R. Squibb & Sons, L.L.C. | $19.85 | 2024 | Sotyktu |
| Organon LLC | $17.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mimi Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.